As a result, the University of Connecticut has alerted 11 scientific journals that studies they published may have included fabricated data.
The University of Connecticut’s Health Center has alerted 11 scientific journals that studies they published that were performed by one of the university’s researchers may have included fabricated data.
Dipak K. Das, PhD, was a professor at the university’s Department of Surgery and was director of the university’s Cardiovascular Research Center. The university says that Das had gained attention in recent years for his research on the beneficial properties of resveratrol.
The university has concluded that Das is guilty on 145 counts of fabrication and falsification of data. The university began its investigation on Das three years ago, thanks to anonymous tips, and worked with the U.S. Office of Research Integrity during the process.
Philip Austin, the university’s interim vice president for health affairs, made sure to underline: “The abuses in one lab do not reflect the overall performance of the Health Center’s biomedical research enterprise, which continues to pursue advances in treatments and cures with the utmost integrity.”
The university says it is now working on dismissal proceedings for Das. Former members of Das’s lab are also facing inquiries, although “no findings have been issued to date,” the university says.
The scientific journals that were notified are:
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.